Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Bio Green Med Solution, Inc./ EFFECT

Notice of Effectiveness · EFFECT

Bio Green Med Solution, Inc.

BGMSNASDAQEQUITYCurrent

Notice of Effectiveness

Filed Oct 8, 2026Accepted Oct 9, 2026, 12:15 AM EDTFiling CIK 1130166Accession 9999999995-26-003182
View company →Permanent SEC source ↗
Share

Structured filing — EFFECT

primary_doc.xml

Open full document ↗

Notice details

Submission type
EFFECT
Act
33

Effectiveness

Effective date
2026-10-08
Effective time (as filed)
17:00:00
Form
S-4

Registrant 1

Registrant
Bio Green Med Solution, Inc.
Registrant CIK
0001130166
File number
333-296815

Company context

We are a clinical-stage biopharmaceutical company working to develop innovative cancer medicines based on cell cycle, epigenetics and mitosis biology. We are a pioneer company in the field of cancer cell cycle biology with a vision to improve patient healthcare by translating insights in cancer biology into medicines that can overcome resistance and ultimately increase a patient’s overall survival.

Current securities

BGMSNASDAQ · EQUITY · CurrentBGMSPOTC · PREFERRED · Current
Historical securities (2)
BGMSPNASDAQ · PREFERRED · Historical · closed Mar 20, 2026CYCCOTC · EQUITY · Historical · closed Sep 11, 2025

Recent company filings

  1. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingNov 4, 2026
  2. S-3 filingOct 23, 2026
  3. Other EventsOct 16, 2026
  4. 424B3 filingOct 9, 2026
  5. S-4/A filingSep 11, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.